I think in the world of Big Pharma the expression "not-for-profit" can be interpreted as meaning "not gouging".
You can hardly expect a company re-priortising existing/taking on additional research related to Covid19 to suddenly go all-in on philanthropy.
Ann: CSL Results Announcement, page-83
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$294.13 |
Change
-0.870(0.29%) |
Mkt cap ! $142.4B | |||
| Open | High | Low | Value | Volume |
| $295.01 | $296.50 | $293.51 | $164.4M | 558.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 136 | $294.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $294.13 | 250 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |